Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesCoding microsatellite instability analysis in microsatellite unstable small intestinal adenocarcinomas identifies MARCKS as a common target of inactivation
Molecular Carcinogenesis, 10/27/09
Michel S et al. – The authors herein present a cMSI profile of MSI–H small intestinal adenocarcinomas identifying MARCKS as a frequent target of mutation. Loss of MARCKS protein expression suggests a significant role of MARCKS inactivation in the pathogenesis of small intestinal adenocarcinomas.
Related Articles
Adenocarcinoma of the small bowel
Saudi Journal of Gastroenterology, 10/05/09
Relevance Score: 80%
Risk Factors for Anastomotic Leakage Following Intersphincteric Resection for Very Low Rectal Adenocarcinoma
Journal of Gastrointestinal Surgery, 10/23/09
Relevance Score: 79%
Renal Metastasis From Primary Colon Cancer on FDG PET-CT
Clinical Nuclear Medicine, 10/06/09
Relevance Score: 78%
Carcinosarcoma of the duodenum: Report of a case
Surgery Today, 10/06/09
Relevance Score: 77%
Squamous cell cancer of the rectum
World Journal of Gastroenterology, 10/01/09
Relevance Score: 77%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: An institutional-based review
Journal of Clinical Oncology, 11/29/09
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 11/29/09
Knockdown of peroxisome proliferator-activated receptor-beta induces less differentiation and enhances cell–fibronectin adhesion of colon cancer cells
Oncogene, 11/25/09
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: A phase II trial
Journal of Clinical Oncology, 11/29/09
Sorafenib in patients with advanced biliary tract carcinoma: A phase II trial
British Journal of Cancer, 11/29/09
A new staging system is more discriminant than conventional staging systems for unresectable hepatocellular carcinoma
Journal of Cancer Research & Clinical Oncology, 11/24/09
Sponsor
Article Search
Sponsor
Sponsor